Option Care Health, Inc.

BMV:OPCH * Stock Report

Market Cap: Mex$76.1b

Option Care Health Valuation

Is OPCH * undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of OPCH * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: OPCH * (MX$628.01) is trading below our estimate of fair value (MX$1038.12)

Significantly Below Fair Value: OPCH * is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for OPCH *?

Key metric: As OPCH * is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for OPCH *. This is calculated by dividing OPCH *'s market cap by their current earnings.
What is OPCH *'s PE Ratio?
PE Ratio17.9x
EarningsUS$208.87m
Market CapUS$3.73b

Price to Earnings Ratio vs Peers

How does OPCH *'s PE Ratio compare to its peers?

The above table shows the PE ratio for OPCH * vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average65x
600763 Topchoice Medical
47.3x16.7%CN¥23.0b
LALPATHLAB Dr. Lal PathLabs
61.4x13.6%₹246.3b
MCOV B Medicover
115.9x40.9%SEK 26.4b
AMED Amedisys
35.6x38.7%US$2.9b
OPCH * Option Care Health
17.9x4.4%Mex$3.7b

Price-To-Earnings vs Peers: OPCH * is good value based on its Price-To-Earnings Ratio (17.9x) compared to the peer average (65x).

Price to Earnings Ratio vs Industry

How does OPCH *'s PE Ratio compare vs other companies in the Global Healthcare Industry?

12 CompaniesPrice / EarningsEstimated GrowthMarket Cap
No. of Companies77PE01632486480+
12 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: OPCH * is good value based on its Price-To-Earnings Ratio (17.9x) compared to the Global Healthcare industry average (20.6x).

Price to Earnings Ratio vs Fair Ratio

What is OPCH *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

OPCH * PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio17.9x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate OPCH *'s Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Médica Sur. de

Mex$3.1b

Operates as a healthcare hospital in Mexico.

MEDICA B

Mex$28.84

7D

-0.6%

1Y

-31.0%

ZimVie

US$186.2m

Develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide.

ZIMV *

US$230.00

7D

0%

1Y

n/a

M3

JP¥880.0b

Provides medical-related services primarily to physicians and other healthcare professionals through Internet.

2413 N

JP¥183.50

7D

0%

1Y

n/a